News | News By Subject | News by Disease News By Date | Search News

Immune/Idiopathic Thrombocytopenic Purpura (ITP) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News

News from Around the Web
No News Posted on that date

Press Releases
Protalex, Inc. (PRTX) Announces Presentation Of Preclinical Data With PRTX-100 Supporting Treatment Of Immune Thrombocytopenia At The American Society of Hematology 57th Annual Meeting And Exposition     11/11/2015
Symphogen A/S and Swedish Orphan Biovitrum Receive U.S. Orphan Drug Designation for Rozrolimupab in ITP     10/6/2010
Immunomedics, Inc. (IMMU) Reports Updated Results of Low-Dose Veltuzumab for Immune Thrombocytopenic Purpura     6/5/2009
CSL Behring Release: Study Shows Privigen(TM) 10% Liquid Immunoglobulin Preparation for Intravenous Use, Is an Effective Replacement Therapy in Patients with Primary Immune Deficiencies     3/17/2008
Endocyte Receives Notice Of A U.S. Patent Allowance For A Targeted Immunotherapy Treatment     11/2/2005
Labeling For Gamunex Now Includes Assurances Of Removal Of Pathogenic Prions During Manufacture; First Liquid IGIV Therapy To Carry FDA-Approved Labeling For TSE Removal Demonstrates Continued Talecris Biotherapeutics Leadership In Pathogen Safety     7/7/2005
CytoGenix, Inc. (CYGX) Invents Revolutionary Large-Scale Manufacturing Process For High-Purity DNA     12/14/2004

//-->